PCN285 THERAPEUTIC BENEFIT OF ORPHAN DRUGS IN ONCOLOGY: EVIDENCE AT THE POINT OF EUROPEAN MARKETING AUTHORISATION
| Title: | PCN285 THERAPEUTIC BENEFIT OF ORPHAN DRUGS IN ONCOLOGY: EVIDENCE AT THE POINT OF EUROPEAN MARKETING AUTHORISATION |
|---|---|
| Authors: | Odnoletkova, I.; Marjenberg, Z.; Pooley, N.; Langham, S. |
| Source: | Value in Health ; volume 22, page S491 ; ISSN 1098-3015 |
| Publisher Information: | Elsevier BV |
| Publication Year: | 2019 |
| Collection: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: | article in journal/newspaper |
| Language: | English |
| DOI: | 10.1016/j.jval.2019.09.480 |
| Availability: | http://dx.doi.org/10.1016/j.jval.2019.09.480; https://api.elsevier.com/content/article/PII:S109830151932858X?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S109830151932858X?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: | edsbas.5CF59334 |
| Database: | BASE |